The Role of Immunotherapy in Multiple Myeloma

Por Kocoglu, Mehmet, Badros, Ashraf
Publicado no Pharmaceuticals (Basel) (2016)

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

Por Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Publicado em 2013

Microenvironment-dependent growth of pre-neoplastic and malignant plasma cells in humanized mice

Por Das, Rituparna, Strowig, Till, Verma, Rakesh, Koduru, Srinivas, Hafemann, Anja, Hopf, Stephanie, Kocoglu, Mehmet H., Borsotti, Chiara, Zhang, Lin, Branagan, Andrew, Eynon, Elizabeth, Manz, Markus G., Flavell, Richard A., Dhodapkar, Madhav V.
Publicado no Nat Med (2016)

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Por Sehgal, Kartik, Das, Rituparna, Zhang, Lin, Verma, Rakesh, Deng, Yanhong, Kocoglu, Mehmet, Vasquez, Juan, Koduru, Srinivas, Ren, Yan, Wang, Maria, Couto, Suzana, Breider, Mike, Hansel, Donna, Seropian, Stuart, Cooper, Dennis, Thakurta, Anjan, Yao, Xiaopan, Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Publicado no Blood (2015)